ACE and chronic kidney disease: Angiotensin-converting enzyme inhibitors (ACEIs) are widely prescribed as first-line drugs in chronic diseases that require long-term treatment and management for patients with hypertension and congestive heart failure, especially for those with chronic kidney disease (CKD) or diabetes mellitus (DM) [1].